Skip to content

Transversus Abdominis Plane Block and Postoperative Pain After Laparoscopic Cholecystectomy

Effect of Subcostal Transversus Abdominis Plane Block on Early Postoperative Pain in Laparoscopic Cholecystectomy: Randomized, Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01595165
Enrollment
50
Registered
2012-05-09
Start date
2012-07-31
Completion date
2013-03-31
Last updated
2012-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Muscles, Laparoscopic Cholecystectomy, Nerve Block, Postoperative Pain

Keywords

laparoscopic cholecystectomy, ultrasound, transversus abdominis plane block

Brief summary

Transversus abdominis plane (TAP) block has gained popularity for the control of postoperative pain in various surgeries. Three studies showed inconsistent result on pain control after TAP block in laparoscopic cholecystectomy. The TAP technique used in these studies was classic ultrasound guided TAP block. Besides periumbilical incision, sub-xiphoid incision is usually made during laparoscopic cholecystectomy. As typical posterior TAP rarely extend above T8, the investigators undergo subcostal TAP block for this type of surgery. The investigators are going to investigate the effect of subcostal TAP on early postoperative pain after laparoscopic cholecystectomy.

Interventions

Under ultrasound guidance0.375% ropivacaine 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.

PROCEDUREPlacebo Ultrasound guided subcostal TAP block

Under ultrasound guidance saline 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.

Sponsors

Soonchunhyang University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II * Age 20-65 patients scheduled elective laparoscopic cholecystectomy

Exclusion criteria

* Patient refusal * Allergy to ropivacaine * Coagulopathy * Morbid obesity (BMI\>35 kg/m2) * Previous abdominal surgery.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale (NRS) 15 min after entering recovery room15 min after entering recovery room

Secondary

MeasureTime frame
Fentanyl consumption at recovery roomUp to 3 hours until discharge from recovery room
Recovery room stayUp to 3 hours from entering recovery room to discharge
Incidence of postoperative nausea and vomiting (PONV)Up to 3 hours during recovery room stay
NRS at 4h, 24h, and 48 h after surgery4h, 24h, and 48 h after surgery

Countries

South Korea

Contacts

Primary ContactSang-Hyun Kim, M.D., Ph.D.
skim@schmc.ac.kr82-32-621-5328

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026